483 Merck Sharp & Dohme Feb 2013

483 Merck Sharp & Dohme Feb 2013

Mihaly Ligmond FDA, Robert Tollefsen FDA, Paula Trost FDA$119.00 - Available Now

FDA investigators audited the Merck Sharp & Dohme - West Point, PA, United States facility and issued inspectional observations (via FDA 483) on 06 Feb 2013.

Product details

  • Category: Biologics
  • Inspection end: 06 Feb 2013
  • Location: West Point, United States
  • FEI: 2510592
Add To Cart